Antiepileptic Drugs Market Is Likely to Experience a Tremendous Growth by 2029

The global antiepileptic drugs market is anticipated to grow at a considerable CAGR of 2.6% during the forecast period. The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launch, and product innovation to remain competitive in the marketplace. For instance, Therachon Holding AG, a privately owned clinical-stage biotechnology business, has been acquired by pfizer Inc. 

Therachon Holding AG is a privately held clinical-stage biotechnology company. Pfizer Inc. paid an additional USD 470 million for Therachon Holding AG, in addition to $340 million, under the terms of the acquisition. Following the fulfilment of major milestones in the marketing and development of TA-46, a further payment of USD 470 million was made. In September 2019, GW Pharmaceuticals plc. launches the new innovations drugs, EPIDYOLEX that are used for the Dravet syndrome or Lennox Gastaut syndrome as an adjunction the therapy of seizures.  

In addition, in May 2021, Epilepsy Foundation, a  U.S. based non-profit national foundation entered into a collaboration with Eisai Inc. is a Japanese pharmaceutical company that developed the Epilepsy Digital Experience Navigator platform designed to empower people with epilepsy. The caregiver and clinician use data to better improvement of the epilepsy journey. Further, in November 2019, SK Biopharmaceuticals, Co., Ltd., a global pharmaceutical company focused on developing and bringing treatments to market for central nervous system (CNS) disorders, announced that the U.S. Food and Drug Administration (FDA) has approved XCOPRI (cenobamate tablets) as a treatment for partial-onset seizures in adults. With the approval of XCOPRI, clinicians will have a new treatment option for patients who are still having focal (partial-onset) seizures. The approval is based on the findings of two global, randomised, double-blind, placebo-controlled studies, as well as a major, global, multi-center, open-label safety study that involved adults with uncontrolled partial-onset seizures who were using one to three anti-epileptic drugs concurrently (AEDs).

To Request a Sample of our Report on Antiepileptic Drugs Market:  https://www.omrglobal.com/request-sample/antiepileptic-drugs-market

Market Coverage

•                 The market number available for – 2021-2029

•                 Base year- 2021

•                 Forecast period- 2022-2029

Segment Covered- 

·                  By Drug Type

Regions Covered-

·                  North America

·                  Europe

·                  Asia-Pacific

·                  Rest of the World

Competitive Landscape- including Abbott Laboratories, GlaxoSmithKline plc, Pfizer Inc., and others.

Antiepileptic Drugs Market Report Segment

By Drug Type

Ø  First Generation AEDs

·        Phenytoin (Dilantin, Phenytek)

·        Carbamazepine (Carbatrol)

·        Oxycarbazepine (Trileptal)

·        Valproate (Depakote)

·        Others

Ø  Second Generation AEDs

·        Lamotrigine (Lamictal)

·        Pregabalin (Lyrica)

·        Rufinamide (Banzel/Inovelon)

·        Levetiracetam (Keppra)

·        Others 

A full Report of Antiepileptic Drugs Market is Available @  https://www.omrglobal.com/industry-reports/antiepileptic-drugs-market

Antiepileptic Drugs Market Report Segment by Region

North America

·        United States

·        Canada

Europe

·        UK

·        Germany

·        Spain

·        France

·        Italy

·        Rest of Europe

Asia-Pacific

·                  India

·                  China

·                  Japan

·                  South Korea

·                  Rest of APAC

Rest of the World

·        Latin America 

·        Middle East & Africa

Company Profiles 

·        Abbott Laboratories

·        Cephalon, Inc.

·        Eisai Co.

·        GlaxoSmithKline plc

·        GW Pharmaceuticals Inc.

·        H. Lundbeck A/S

·        Johnson & Johnson

·        Novartis AG

·        Pfizer Inc.

·        Sanofi S.A.

·        Sunovion Pharmaceuticals Inc.

·        Takeda Pharmaceutical Co. Ltd.

·        UCB S.A.

·        Valeany Pharmaceuticals International Inc.

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more